OTCMKTS:TPIY

Tianyin Pharmaceutical Stock Forecast, Price & News

$0.0001
0.00 (0.00 %)
(As of 07/15/2019)
Add
Compare
Today's Range
$0.00
▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
▼
$0.02
Volume88,900 shs
Average Volume36,100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta54.39
30 days | 90 days | 365 days | Advanced Chart
Receive TPIY News and Ratings via Email

Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.


About Tianyin Pharmaceutical

Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.

Headlines

OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of September
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of September
February 10, 2020 |  www.bloomberg.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.58 out of 5 stars

Medical Sector

1459th out of 2,100 stocks

Pharmaceutical Preparations Industry

645th out of 831 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Tianyin Pharmaceutical (OTCMKTS:TPIY) Frequently Asked Questions

What stocks does MarketBeat like better than Tianyin Pharmaceutical?

Wall Street analysts have given Tianyin Pharmaceutical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tianyin Pharmaceutical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Tianyin Pharmaceutical's stock been impacted by COVID-19 (Coronavirus)?

Tianyin Pharmaceutical's stock was trading at $0.0001 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TPIY stock has increased by 0.0% and is now trading at $0.0001.
View which stocks have been most impacted by COVID-19.

Who are Tianyin Pharmaceutical's key executives?

Tianyin Pharmaceutical's management team includes the following people:
  • Guo Qing Jiang, Chairman, President & Chief Executive Officer
  • Tao Yang, Chief Operating Officer
  • Li Ying Wang, Financial Controller
  • Ying Zhang, Director-Human Resources

Who are some of Tianyin Pharmaceutical's key competitors?

Some companies that are related to Tianyin Pharmaceutical include Acusphere (ACUS), ADiTx Therapeutics (ADTX), Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), China Dongsheng International (CDSG), China Health Industries (CHHE), Diadexus (DDXSQ), ERBA Diagnostics (ERBA), GelStat (GSAC), Global Future City (FTCY), Imagenetix (IAGX), Immune Therapeutics (IMUN) and Interpharm (IPAH).
View all of TPIY's competitors.

What other stocks do shareholders of Tianyin Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include Northern Oil and Gas (NOG) and International Business Machines (IBM).

What is Tianyin Pharmaceutical's stock symbol?

Tianyin Pharmaceutical trades on the OTCMKTS under the ticker symbol "TPIY."

How do I buy shares of Tianyin Pharmaceutical?

Shares of TPIY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tianyin Pharmaceutical's stock price today?

One share of TPIY stock can currently be purchased for approximately $0.00.

What is Tianyin Pharmaceutical's official website?

The official website for Tianyin Pharmaceutical is www.tianyinpharma.com.

Where are Tianyin Pharmaceutical's headquarters?

Tianyin Pharmaceutical is headquartered at 23RD FLOOR UNIONSUN YANGKUO PLAZA NO.2 BLOCK 3 RENMIN ROAD SOUTH, CHENGDU P.R. F4, 610041.

How can I contact Tianyin Pharmaceutical?

Tianyin Pharmaceutical's mailing address is 23RD FLOOR UNIONSUN YANGKUO PLAZA NO.2 BLOCK 3 RENMIN ROAD SOUTH, CHENGDU P.R. F4, 610041. The company can be reached via phone at 00-86-028-8551-6696 or via email at [email protected]


This page was last updated on 6/18/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.